Norris Medicines informs about standalone audited financial results

26 May 2018 Evaluate

Pursuant to Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, Norris Medicines has informed about submission of the Standalone Audited Financial Results of the Company for the quarter and Year ended 31st March, 2018; Auditor's Report by Statutory Auditors on Audited Financial Results for the quarter and Year ended 31st March, 2018; and declaration pursuant to Regulation 33 (d) of (Listing Obligation and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Norris Medicines Share Price

15.50 -1.25 (-7.46%)
29-Dec-2025 11:17 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.60
Dr. Reddys Lab 1262.90
Cipla 1500.35
Zydus Lifesciences 904.60
Lupin 2093.75
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×